The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.
 
Martin J. Van Den Bent
Consulting or Advisory Role - Abbvie; Agios; Bristol-Myers Squibb; Celgene; Celldex; Daiichi Sankyo; MSD
Research Funding - Abbvie (Inst)
 
Sara Erridge
No Relationships to Disclose
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Honoraria - Medicenna
Research Funding - DNAtrix (Inst); Infusion Therapeutics (Inst); Medicenna (Inst); Tocagen (Inst)
Patents, Royalties, Other Intellectual Property - Patents for drug delivery devices for the brain
Travel, Accommodations, Expenses - Infusion Therapeutics
 
Anna K. Nowak
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Douglas Pharmaceuticals; Douglas Pharmaceuticals; Epizyme; Merck Sharp & Dohme; Roche; Sellas Life Sciences; Trizell
Research Funding - AstraZeneca (Inst); Douglas Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim
 
Marc Sanson
No Relationships to Disclose
 
Alba Ariela Brandes
No Relationships to Disclose
 
Wolfgang Wick
Consulting or Advisory Role - Abbvie
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)
 
Jean-Francois Baurain
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Research Funding - Amgen; MSD
Travel, Accommodations, Expenses - MSD
 
Warren P. Mason
No Relationships to Disclose
 
Helen Wheeler
No Relationships to Disclose
 
Michael Weller
Honoraria - Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck Serono; Orbus Therapeutics; Pfizer; Teva; Tocagen
Research Funding - Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)
 
Kenneth D. Aldape
Consulting or Advisory Role - Celldex
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - Merck
 
Pieter Wesseling
No Relationships to Disclose
 
Johan M. Kros
No Relationships to Disclose
 
Mircea Tesileanu
No Relationships to Disclose
 
Vassilis Golfinopoulos
No Relationships to Disclose
 
Thierry Gorlia
No Relationships to Disclose
 
Brigitta G. Baumert
Honoraria - Roche
Consulting or Advisory Role - Noxxon Pharma; Roche/Genentech
Travel, Accommodations, Expenses - Noxxon Pharma; Roche Pharma AG
 
Pim French
Employment - Bristol-Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie